CellaVision AB (ST:CEVI) — Stock Price

Skr152.40 SEK
▲ 0.00% today

CellaVision AB (ST:CEVI) is currently trading at Skr152.40 SEK, up 0.00% today. Over the past 52 weeks, shares have ranged between Skr118.40 and Skr188.40. This page tracks CellaVision AB's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see CellaVision AB (CEVI) market capitalisation.

CellaVision AB (CEVI) Stock Price Chart — Daily History & Trading Volume

The chart below tracks CellaVision AB's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

CellaVision AB Income Statement — Revenue, Profit & Earnings by Year

CellaVision AB's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Skr758.97 Million Skr723.22 Million Skr677.29 Million Skr639.34 Million Skr565.55 Million
Cost of Revenue Skr239.09 Million Skr236.14 Million Skr214.25 Million Skr201.02 Million Skr173.25 Million
Gross Profit Skr519.88 Million Skr487.07 Million Skr463.04 Million Skr438.32 Million Skr392.30 Million
Research & Development Skr97.58 Million Skr87.45 Million Skr83.33 Million Skr88.55 Million Skr64.25 Million
SG&A Skr90.34 Million Skr85.36 Million Skr76.03 Million Skr73.54 Million Skr63.08 Million
Total Operating Expenses Skr317.80 Million Skr309.39 Million Skr295.99 Million Skr280.05 Million Skr229.57 Million
Operating Income Skr202.07 Million Skr177.68 Million Skr167.05 Million Skr158.27 Million Skr162.73 Million
EBITDA Skr237.28 Million Skr219.75 Million Skr207.25 Million Skr198.36 Million Skr193.60 Million
EBIT Skr204.98 Million Skr185.02 Million Skr167.48 Million Skr158.27 Million Skr160.16 Million
Interest Expense Skr10.71 Million Skr8.16 Million Skr3.26 Million Skr2.34 Million Skr1.87 Million
Income Before Tax Skr194.26 Million Skr176.86 Million Skr164.22 Million Skr148.43 Million Skr158.30 Million
Income Tax Expense Skr41.19 Million Skr36.14 Million Skr33.91 Million Skr30.09 Million Skr32.96 Million
Net Income Skr153.08 Million Skr140.72 Million Skr130.31 Million Skr118.33 Million Skr125.34 Million

CellaVision AB Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes CellaVision AB's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Skr1.09 Billion Skr1.01 Billion Skr928.71 Million Skr891.75 Million Skr825.21 Million
Total Current Assets Skr441.09 Million Skr401.65 Million Skr365.59 Million Skr377.14 Million Skr364.72 Million
Cash & Equivalents — — — — —
Short-term Investments — — — Skr-5.15 Million Skr-21.79 Million
Net Receivables Skr141.07 Million Skr125.28 Million Skr97.80 Million Skr119.41 Million Skr114.56 Million
Inventory Skr111.81 Million Skr124.82 Million Skr126.04 Million Skr142.57 Million Skr115.09 Million
Property, Plant & Equipment Skr122.37 Million Skr119.94 Million Skr125.50 Million Skr110.03 Million Skr80.33 Million
Goodwill Skr120.68 Million Skr128.14 Million Skr123.78 Million Skr124.14 Million Skr114.08 Million
Total Liabilities Skr207.31 Million Skr196.16 Million Skr212.32 Million Skr250.12 Million Skr281.93 Million
Total Current Liabilities Skr110.93 Million Skr107.95 Million Skr119.15 Million Skr133.09 Million Skr134.50 Million
Long-term Debt Skr11.97 Million Skr12.68 Million Skr28.66 Million Skr60.36 Million Skr95.84 Million
Net Debt Skr-162.56 Million Skr-122.58 Million Skr-56.94 Million Skr-5.56 Million Skr6.37 Million
Total Stockholder Equity Skr887.58 Million Skr815.73 Million Skr716.39 Million Skr641.63 Million Skr543.28 Million
Retained Earnings — Skr771.62 Million Skr684.56 Million Skr607.92 Million Skr537.28 Million

CellaVision AB Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how CellaVision AB generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Skr200.53 Million Skr198.44 Million Skr196.44 Million Skr137.28 Million Skr159.72 Million
Capital Expenditures Skr18.81 Million Skr77.75 Million Skr86.48 Million Skr69.43 Million Skr84.31 Million
Free Cash Flow Skr181.72 Million Skr120.69 Million Skr109.96 Million Skr67.85 Million Skr75.41 Million
Investing Cash Flow Skr-86.16 Million Skr-76.01 Million Skr-85.53 Million Skr-70.01 Million Skr-84.34 Million
Financing Cash Flow Skr-74.59 Million Skr-95.09 Million Skr-97.04 Million Skr-90.41 Million Skr-48.48 Million
Dividends Paid Skr59.63 Million Skr53.67 Million Skr53.67 Million Skr47.70 Million Skr17.89 Million
Stock-Based Compensation — — — — —
Depreciation Skr32.31 Million Skr41.01 Million Skr39.76 Million Skr40.10 Million Skr33.44 Million
Change in Cash Skr38.79 Million Skr27.79 Million Skr13.59 Million Skr-22.23 Million Skr28.02 Million

CellaVision AB Earnings History — EPS Actual vs. Analyst Estimates

Track CellaVision AB's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 23, 2026 — 1.64 —
Feb 05, 2026 1.79 1.79 -0.19%
Nov 06, 2025 1.31 1.43 -8.39%
Jul 18, 2025 1.58 1.65 -4.24%
Apr 29, 2025 1.74 1.47 +18.37%
Feb 06, 2025 1.72 1.96 -12.24%
Oct 24, 2024 1.30 1.75 -25.71%
Jul 19, 2024 1.62 1.75 -7.43%